Back to results
US 2019/0376061 A1Published application
IncRNAS FOR THERAPY AND DIAGNOSIS OF ANGIOGENESIS
AssigneeMedizinische Hochschule Hannover
InventorsThomas THUM, Jan Fiedler
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeMedizinische Hochschule Hannover
InventorsThomas THUM, Jan Fiedler
Estimating the term…
The present invention relates to a pharmaceutical composition comprising (i) a compound promoting the expression and/or the activity of one or more long non-coding RNAs (lncRNAs) selected from SEQ ID NOs 1 to 22, preferably selected from SEQ ID NOs 1 to 3; and/or (ii) a compound inhibiting the expression and/or the activity of one or more lncRNAs selected from SEQ ID NOs 23 to 42. The present invention also relates to a pharmaceutical composition comprising (i) a compound promoting the expression and/or the activity of one or more lncRNAs selected from SEQ ID NOs 23 to 42; and/or (ii) a compound inhibiting the expression and/or the activity of one or more long non-coding RNAs (lncRNAs) selected from SEQ ID NOs 1 to 22, preferably selected from SEQ ID NOs 1 to 3.
1-15. (canceled)
A method for treating or preventing a tumor, or for treating or preventing diabetic retinopathy comprising administering to a subject in need thereof a compound inhibiting the expression and/or the activity of one or more lncRNAs selected from SEQ ID NOs 1 to 3.
A method for treating or preventing ischemia, or for promoting wound healing comprising administering to a subject in need thereof a compound promoting the expression and/or the activity of one or more lncRNAs selected from SEQ ID NOs 1 to 3.
Dependencies are inferred from the claim text.